# Pediatric Concussion Outcomes

> **NCT04226365** · PHASE4 · TERMINATED · sponsor: **Lancaster General Hospital** · enrollment: 8 (actual)

## Conditions studied

- Concussion Post Syndrome
- Headaches Posttraumatic
- Mild Traumatic Brain Injury

## Interventions

- **DRUG:** Nortriptyline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04226365
- **Lead sponsor:** Lancaster General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-15
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** The study was stopped prematurely due to a low enrollment rate.
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04226365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04226365, "Pediatric Concussion Outcomes". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04226365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*